- Home
- BY vs GPCR Comparison
BY vs GPCR Comparison
Compare BY & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BY
- GPCR
- Stock Information
- Founded
- BY 1914
- GPCR 2016
- Country
- BY United States
- GPCR United States
- Employees
- BY N/A
- GPCR N/A
- Industry
- BY Major Banks
- GPCR
- Sector
- BY Finance
- GPCR
- Exchange
- BY Nasdaq
- GPCR Nasdaq
- Market Cap
- BY 1.3B
- GPCR 1.1B
- IPO Year
- BY 2017
- GPCR 2023
- Fundamental
- Price
- BY $28.95
- GPCR $21.11
- Analyst Decision
- BY Hold
- GPCR Strong Buy
- Analyst Count
- BY 3
- GPCR 9
- Target Price
- BY $33.00
- GPCR $75.63
- AVG Volume (30 Days)
- BY 183.9K
- GPCR 1.1M
- Earning Date
- BY 10-23-2025
- GPCR 11-12-2025
- Dividend Yield
- BY 1.38%
- GPCR N/A
- EPS Growth
- BY N/A
- GPCR N/A
- EPS
- BY 2.68
- GPCR N/A
- Revenue
- BY $384,591,000.00
- GPCR N/A
- Revenue This Year
- BY $17.79
- GPCR N/A
- Revenue Next Year
- BY $3.36
- GPCR N/A
- P/E Ratio
- BY $10.84
- GPCR N/A
- Revenue Growth
- BY 2.48
- GPCR N/A
- 52 Week Low
- BY $22.63
- GPCR $13.22
- 52 Week High
- BY $32.89
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- BY 58.61
- GPCR 59.60
- Support Level
- BY $28.59
- GPCR $20.29
- Resistance Level
- BY $29.75
- GPCR $21.49
- Average True Range (ATR)
- BY 0.71
- GPCR 1.12
- MACD
- BY -0.04
- GPCR 0.13
- Stochastic Oscillator
- BY 80.34
- GPCR 70.52
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.